SLC5A2 and endothelial dysfunction: SGLT-2 inhibitors are known to have pleiotropic effects in the prevention of atherosclerotic cardiovascular disease by inhibiting vascular inflammation, reducing oxidative stress, improving endothelial dysfunction, preventing platelet activation, and reducing foam cell formation.